Pyoderma gangrenosum
Also known as: PG, Ulcerative pyoderma gangrenosum, Neutrophilic ulcerative dermatosis, Peristomal pyoderma gangrenosum
Pyoderma gangrenosum (PG) is a rare autoinflammatory neutrophilic dermatosis characterised by painful ulceration, typically exhibiting undermined borders. The condition can resemble or coexist with secondary infection and is often associated with systemic disease, including haematological disorders. Given that cutaneous trauma may provoke further lesions, procedural decisions require particular caution. Management necessitates dermatology-led assessment, appropriate wound care, analgesia, and prescribed systemic treatment; peristomal presentations require specialist stoma care. The cited evidence comprises case reports and a nursing review; there are no clinical trials evaluating acupuncture or Chinese herbal medicine for this condition. TCM patterns provided serve exclusively as traditional assessment frameworks. Adjunctive care must be coordinated with the treating team and must not delay diagnosis, infection assessment, or established treatment.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to the prescribed wound-management protocol; handle affected tissues with care and avoid mechanical trauma, including excoriation or friction from adhesive materials.
- •Maintain nutritional status with adequate protein and fluid intake; refer for dietetic assessment if appetite is diminished or unintentional weight loss occurs.
- •Adjust activities of daily living according to pain threshold and fatigue levels; implement measures to mitigate friction or pressure over compromised skin.
- •Document pain levels and wound characteristics systematically; utilise clinical photography only as directed by the treating team and maintain all scheduled dermatological and stoma-care appointments.
Cautions & Contraindications
- •Do not needle ulcers, inflamed margins, new lesions or recently traumatised skin. Needle-site lesions in the supplied case illustrate pathergy risk; even distant intact skin cannot be assumed safe.[]
- •Defer elective acupuncture during rapidly progressive disease, suspected secondary infection or systemic illness; prioritise medical reassessment, particularly during immunosuppression.[,]
- •Avoid elective debridement or other tissue-traumatising adjunctive procedures without specialist direction. Selected surgery may be appropriate within coordinated PG and infection management, not as routine adjunctive care.[,]
- •Do not needle through stoma appliances or peristomal skin, or introduce unapproved topical products beneath dressings; coordinate local care with the stoma and wound teams.[]
When to reassess or seek care again
Follow the specialist's wound-review schedule; if adjunctive support is agreed, review within 7–14 days using pain scores, sleep disruption, function, appetite and adverse effects. Use clinician-recorded ulcer dimensions and photographs to track disease without additional trauma. Escalate immediately for new lesions, ulcer expansion, infection signs or deterioration after any intervention. At 2–4 weeks, discontinue or revise adjunctive care if there is no measurable supportive benefit; do not use this interval to postpone specialist escalation.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Frontiers in medicine · 2026
- Frontiers in immunology · 2026
- Frontiers in medicine · 2026
- Frontiers in medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
